Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,135 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02399527Recruiting
Lymphatic problem registry for tracking outcomes
This study enrolls people with certain lymphatic (lymph fluid) conditions to collect information and track how they do over time. It may help doctors better understand outcomes and improve care.
Boston, MassachusettsAges Any age - NCT02573532Recruiting
Tracking heart damage after non-cardiac surgery
This study looks at whether patients experience heart muscle injury during or shortly after non-cardiac surgery. It aims to understand how common this is and what it means for recovery.
Basel, Canton of Basel-CityAges 45 years+ - NCT02234388Recruiting
Registry for people with undifferentiated connective tissue disease
This is a study that enrolls people who have early or unclear signs of an autoimmune connective tissue problem. It aims to better understand these conditions over time, which may help future diagnosis and treatment planning.
New York, New YorkAges 18 years+ - NCT02310178Recruiting
Long-term follow-up after bariatric surgery at Montpellier
This study follows people who have had weight-loss surgery at Montpellier University Hospital to see how they do over time. It helps doctors understand the long-term benefits and challenges after surgery.
MontpellierAges 15 years+ - NCT02416388RecruitingPhase 2/Phase 3
Trial for AML treatments and preventing graft-versus-host disease
This trial tests different chemotherapy induction, consolidation (follow-up treatment), and strategies to prevent complications after an allogeneic stem cell transplant. It aims to improve overall survival and reduce serious transplant side effects like graft-versus-host disease (GVHD).
AmiensAges 18–61 - NCT01401998Recruiting
Study collecting information from people with ARPKD
This study looks at medical records, imaging, and genetic testing for people with autosomal recessive polycystic kidney disease (ARPKD). It may help researchers better understand the condition and how it affects the liver and kidneys.
Washington D.C., District of ColumbiaAges Up to 18 years - NCT02118922Recruiting
Testing a light-scanning eye exam to diagnose corneal thinning
This study tests whether a special “Brillouin” microscope scan can spot corneal ectasia and related cornea conditions. It may help doctors diagnose problems earlier and better sort out who needs closer eye care.
Boston, MassachusettsAges 20–75 - NCT01832324Enrolling by invitation
Study the causes of food allergy using blood samples
This study looks for the biological reasons behind food allergies by collecting a small amount of blood. It may help scientists better understand different types of food allergy and eventually improve diagnosis or treatments.
Philadelphia, PennsylvaniaAges 1 month–65 years - NCT02040714Enrolling by invitation
Study of current treatments for Perthes hip disease
This study follows children (and teens) with Legg-Calvé-Perthes disease to learn about how today’s treatments work in real life. It may help doctors choose the best next steps for your child’s hip health.
Birmingham, AlabamaAges 1–18 - NCT02048332RecruitingPhase 1/Phase 2
Donor immune cells for preventing infections after stem cell transplant
This trial studies donor-made immune cells (T-cells) given after a stem cell transplant to help your body fight infections. It aims to test how safe the treatment is and whether it supports the immune system in the months after transplant.
Akron, OhioAges 4 weeks+ - NCT01717924Recruiting
Surgery vs first chemotherapy for stomach signet ring cancer
This trial compares doing surgery first versus starting chemotherapy first for people with resectable signet ring–type stomach cancer. It aims to find which approach works better to cure the cancer and prevent spread.
LilleAges 18–80 - NCT01761981Recruiting
Registry for patients with hereditary bleeding vessel disease (HHT)
This is a patient registry that collects information about people with hereditary hemorrhagic telangiectasia (HHT). It may help doctors better understand the condition and improve care over time.
Buenos Aires, Buenos AiresAges Any age - NCT01957696Enrolling by invitation
Study of pancreas (and sometimes kidney) transplant outcomes
This study looks at people who receive a pancreas transplant, with or without a same-time kidney transplant, and follows them to understand their results. It may help improve how transplant teams choose patients and manage care after surgery.
OsloAges 18–65 - NCT01881503Enrolling by invitation
Hemopure for life-threatening anemia when blood transfusions aren’t an option
This study offers HBOC-201 (Hemopure), a type of blood substitute made from bovine (beef) hemoglobin, to treat severe, life-threatening anemia. It’s meant for adults who have very low hemoglobin with serious signs of poor oxygen delivery, and who can’t (or don’t qualify) for standard blood transfusions.
Englewood, New JerseyAges 18–80 - NCT01855633Recruiting
Brain stimulation therapy for arm or leg weakness after stroke
This trial studies whether repeated magnetic pulses to the brain can improve movement in people with weakness after a stroke. It may help if your stroke happened more than 2 weeks ago and you can safely receive the magnetic treatment.
Hwaseong-si, Gyeonggi-doAges 18 years+ - NCT01868490Enrolling by invitationPhase 1/Phase 2
Testing a patient’s immune cells for advanced solid tumors
This trial tests a modified version of your own immune cells (made from your blood) to help treat advanced cancers that are no longer responding to standard treatment. It’s designed mainly to see if the approach is safe and how well it may work for people whose disease has progressed.
Bangkoknoi, BangkokAges 8–60 - NCT01852448Recruiting
Study genes affecting insulin in people with cystic fibrosis
This study looks at how genes may affect insulin and “incretin” hormones in people with cystic fibrosis. It may help researchers understand why some people develop blood-sugar problems and how to predict or prevent them.
Philadelphia, PennsylvaniaAges 2 years+ - NCT01659203RecruitingPhase 1/Phase 2
Proton or photon radiation for retroperitoneal sarcoma
This trial tests two types of external beam radiation—protons or photons—in people with retroperitoneal (in the back of the abdomen) soft tissue sarcoma. It’s an early-phase study meant to see how well the radiation can control measurable tumors while tracking safety.
Chicago, IllinoisAges 18 years+ - NCT01518400Recruiting
Sharing childhood cancer history to improve survivor care
This study builds a database of people who were diagnosed with cancer as children or teens. It looks at survivors who are done with treatment and currently have no evidence of disease, to help improve long-term follow-up care.
Los Angeles, CaliforniaAges Any age - NCT01293214Recruiting
Transplanting new tissue for multiple amputated limbs
This trial studies whether a transplant of tissue and blood vessels can improve function after limb amputations when prosthetic devices have not worked. It requires long-term medicines to prevent rejection, close follow-up, and intensive rehabilitation.
Boston, MassachusettsAges 18–60 - NCT02134574Recruiting
Study of blood cancers in adults in southern France
This study follows adults who are being checked for a possible blood cancer, or who were recently diagnosed with a blood cancer within the last 6 months. It may help doctors understand the condition better and improve how early workups and care are organized.
MontpellierAges 18 years+ - NCT02098863Recruiting
Research program for people with sickle cell disease on hydroxyurea
This trial program studies sickle cell disease and how treatment works, especially for people who are already taking hydroxyurea at a stable, maximum tolerated dose. It may help researchers better understand treatment effects and side effects in real patients.
Peoria, IllinoisAges Any age - NCT01696721Recruiting
Pediatric radiation therapy registry for children under 22
This study is a registry that collects information from children and teens who receive radiation therapy at participating hospitals. It helps researchers learn how radiation is used in pediatrics and may improve future care.
Palo Alto, CaliforniaAges Up to 21 years - NCT02061306Recruiting
Study of gut microbes and genetics in infant celiac risk
This study looks at how gut bacteria, diet, and family background may relate to celiac disease risk in very young infants. It may help researchers understand why celiac disease happens and how it could be prevented or detected earlier.
Boston, MassachusettsAges Up to 6 months
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,135 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.